22 July 2026
22 July 2026
If introduced, the 100% tariffs would apply to all generics imported to the US, which make up 90% of the nation’s prescriptions.
In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.
Clinical data supporting the expanded approval come from the Phase I/II open-label multi-centre BUR-CL207 trial.
Novartis continues to navigate a decisive period as newer portfolio assets start to offset patent pressures.
Under the collaboration, Cellares will adapt the PPL-001 manufacturing process for its Cell Shuttle platform.
While progress has been made to influence the treatment landscape of Alzheimer’s disease, gaps to widespread therapeutic availability and imaging remain.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
